Nexalin Technology NXL 深 滬
已收盤 11-06 16:00:00 美东时间
1.47
+0.070
+5.00%
華盛通- 最 高1.50
- 今 開1.48
- 成交量 2.14万股
- 最 低 1.3101
- 昨 收 1.40
- 總市值 154.13万
- 52周最高 33.60
- 市盈率 靜 --
- 換手率 2.04%
- 52周最低 1.31
- 委 比 -6.54%
- 總股本 104.85万
- 歷史最高 134.697
- 量 比 1.36
- 振 幅 13.56%
- 歷史最低 1.31
- 每 手 1
- 風險率 8.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nexalin Technology Announces Publication Of Fourth Peer-Reviewed Article Reporting Results From Clinical Research On 15 mA DIFS Technology In Alzheimer's Disease
Results from the randomized, double-blind, sham-controlled TRANSFORM-AD study published in the Journal of Alzheimer's Disease, a recognized international peer-reviewed journal Statistically significant improvement in sleep quality versus sham (p < 0.001) with no serious adverse events; authors descr...
10-27 21:04
Nexalin Signs South America Neurostimulation Distribution Agreement
An update from Nexalin Technology, Inc. ( ($NXL) ) is now available. On Septemb...
10-02 05:57
Nexalin Regains Nasdaq Compliance Amid Ongoing Listing Risks
Nexalin Technology, Inc. ( ($NXL) ) just unveiled an announcement. On September...
10-02 05:56
Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy
Nexalin Technology appoints Robert DiTota as Senior Strategic Advisor to expand its DIFS™ platform from clinical development to commercialization in the U.S., Europe, and South America. DiTota, with over two decades of experience in neuromodulation at Abbott and Medtronic, will help build distribution networks and commercial infrastructure. Nexalin’s Gen-2 SYNC device is already approved in China, Brazil, Oman, and Israel, and the company aims to...
09-29 13:00
Nexalin Technology Granted Conditional Nasdaq Listing Extension
The latest update is out from Nexalin Technology, Inc. ( ($NXL) ). On September...
09-29 05:51
Nexalin Technology shares are trading lower after the company announced a 1-for-30 reverse stock split.
Nexalin Technology shares are trading lower after the company announced a 1-for-30 reverse stock split.
08-28 00:53
Nexalin Announces 1-for-30 Reverse Stock Split Approval
Nexalin Technology, Inc. ( ($NXL) ) has provided an update. Nexalin Technology,...
08-27 19:59
Nexalin Technology Announces Reverse Stock Split
Nexalin Technology, Inc. (Nasdaq: NXL) has approved a 1-for-30 reverse stock split to maintain compliance with Nasdaq's bid-price rule. The split will take effect on August 28, 2026, with shares trading under the new CUSIP number on August 31. Each 30 shares will combine into one, with no change to the $0.001 par value. Fractional shares will result in cash payments. The company's neurostimulation products aim to address mental health disorders, ...
08-27 11:25
